billHR6199Event Thursday, November 20, 2025Analyzed

Medical Nutrition Therapy Act of 2025

Bullish
Impact4/10

Summary

Bipartisan bill to expand Medicare MNT coverage to obesity, cancer, eating disorders, and HIV/AIDS — currently in early House committee stage with 17 cosponsors and a companion Senate bill. Expands the addressable market for nutrition therapy services within Medicare by 3-5x. UNH and CVS stand to benefit from increased patient volume in their integrated care and pharmacy networks, though passage is not guaranteed in 2026.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR6199 expands Medicare MNT coverage to obesity, eating disorders, cancer, HIV/AIDS — a 3-5x increase in addressable Medicare beneficiaries for nutrition therapy.
  • 2.Bill is early-stage (referred to two committees) with companion Senate bill; no CBO score or committee markup yet.
  • 3.UNH and CVS have the integrated care infrastructure to capture MNT patient volume through their clinics and Medicare Advantage plans.
  • 4.No specific funding amount is authorized; increased coverage would be paid through existing Medicare Part B framework.
  • 5.30-day price trends for UNH (+35.54%) and CVS (+15.98%) are driven by broader earnings momentum, not this bill.

Market Implications

UNH at $366.75 and CVS at $83.30 have already rallied significantly in the past 30 days. HR6199's expansion of MNT represents a modest additional tailwind if passed, but neither stock currently prices in any probability of this bill. Near-term focus should be on committee markups and CBO scoring, which would be the first material catalysts. For retail investors, this is a low-probability/high-impact legislative event that adds optionality to existing positions in integrated care plays but does not justify a standalone bet.

Full Analysis

The Medical Nutrition Therapy Act of 2025 (HR6199) was introduced in the House on November 20, 2025, by Rep. Kelly (D-IL) with 17 cosponsors. It has been referred to the Energy and Commerce and Ways and Means committees. A companion bill (S3934) was introduced in the Senate on March 25, 2026. The bill is in its early stages and faces a competitive legislative calendar in the 119th Congress. The money trail: The bill does not authorize or appropriate any specific dollar amount. It amends Section 1861 of the Social Security Act to expand the definition of covered medical nutrition therapy services under Medicare Part B. Any spending increase would be scored by CBO as increased Medicare outlays, offset by potential reductions in hospitalizations and disease progression costs that the bill cites in its findings. Structural winners: Integrated healthcare payers and providers with in-house nutrition/dietary service capabilities — specifically UNH (Optum clinics and UnitedHealthcare Medicare Advantage) and CVS (MinuteClinic, HealthHUB, Aetna MA). These companies have the direct care delivery infrastructure to capture the new MNT referrals. Pure-play nutrition services are primarily private-practice dietitians (not publicly traded) and thus not captured. Real market data analysis: Over the past 30 days, UNH has surged +35.54% from ~$270 to $366.75, and CVS has gained +15.98% from ~$72 to $83.30, both outpacing the broader market. These moves predate any specific progress on this bill — they reflect sector-level earnings momentum. The bill's early stage means current stock prices likely do not price in any MNT expansion premium. Timeline: The bill must pass the House Energy and Commerce and Ways and Means committees, then the full House, then be reconciled with S3934, and be signed into law. With a presidential election year (2026 midterms), the window for major healthcare legislation is narrow. Passage probability is low in 2026.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Strong

Multiple independent sources confirm this signal’s market thesis

Confirmed by:
$$UNH▲ Bullish
Est. $50.0M$200.0M revenue impact

What the bill does

Expansion of Medicare Part B coverage for medical nutrition therapy (MNT) to additional chronic conditions (obesity, eating disorders, cancer, HIV/AIDS) and broadening referral authority to PAs, NPs, CNSs, and clinical psychologists.

Who must act

Medicare Administrative Contractors (MACs) under CMS; UnitedHealthcare Medicare Advantage plans

What happens

Increases the number of Medicare beneficiaries eligible for MNT from the current narrow set (diabetes, renal disease) to all Part B enrollees with qualifying chronic conditions. This expands the addressable patient population by an estimated 3–5x, creating new billable service volume for nutrition providers.

Stock impact

UnitedHealth's Optum segment operates a network of ~60,000 employed or affiliated physicians and a large PBM (Optum Rx). Expanding MNT coverage increases patient visits to Optum's primary care and specialty clinics, generating new fee-for-service and value-based care revenue. UnitedHealthcare Medicare Advantage plans can incorporate MNT as a supplemental benefit, improving star ratings and member retention.

$$CVS▲ Bullish
Est. $20.0M$100.0M revenue impact

What the bill does

Expansion of Medicare Part B coverage for medical nutrition therapy to chronic conditions, with referral authority broadened beyond physicians.

Who must act

CVS Health's MinuteClinic and HealthHUB locations; Aetna Medicare Advantage plans

What happens

CVS operates over 1,100 MinuteClinics and 1,000 HealthHUB locations where nurse practitioners and PAs can now directly refer patients for MNT. This removes the current barrier of requiring a separate physician referral, enabling in-store referrals during same-day visits. Increased patient utilization of nutrition counseling services drives foot traffic and pharmacy/OTC sales.

Stock impact

Aetna Medicare Advantage members (~4.1M) gain access to MNT as a covered benefit, potentially improving CMS quality star ratings. MinuteClinic visits that identify a chronic condition can immediately refer to a registered dietitian within CVS's HealthHUB network, creating a closed-loop service that differentiates CVS from standalone pharmacies and grocers.

Market Impact Score

4/10
Minimal ImpactModerateMajor Market Event

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderApr 18, 2026

Accelerating Medical Treatments for Serious Mental Illness

This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.